XXEC Inc. Invests $18.36 Million in Heartflow, Inc. $HTFL

XXEC Inc. acquired a new stake in shares of Heartflow, Inc. (NASDAQ:HTFL) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 599,194 shares of the company’s stock, valued at approximately $18,364,000. Heartflow makes up 0.0% of XXEC Inc.’s investment portfolio, making the stock its 20th largest position. XXEC Inc. owned approximately 0.69% of Heartflow at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Caitong International Asset Management Co. Ltd acquired a new stake in Heartflow during the 4th quarter worth approximately $27,000. Russell Investments Group Ltd. acquired a new position in shares of Heartflow in the fourth quarter valued at approximately $45,000. Essential Partners LLC bought a new stake in shares of Heartflow during the first quarter worth $57,000. Legal & General Group Plc acquired a new stake in shares of Heartflow during the third quarter worth $59,000. Finally, Strs Ohio acquired a new stake in shares of Heartflow during the fourth quarter worth $99,000.

Insider Transactions at Heartflow

In other Heartflow news, CEO John C.M. Farquhar sold 38,900 shares of the business’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the transaction, the chief executive officer owned 457,935 shares of the company’s stock, valued at $16,027,725. The trade was a 7.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $41.23, for a total value of $380,099.37. Following the completion of the sale, the insider owned 86,459 shares in the company, valued at $3,564,704.57. This represents a 9.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 191,271 shares of company stock valued at $7,089,136 in the last quarter. 7.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Canaccord Genuity Group upped their target price on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. Freedom Capital upgraded Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Stifel Nicolaus upped their price objective on Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. JPMorgan Chase & Co. increased their price objective on Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Finally, Robert W. Baird set a $45.00 target price on Heartflow in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $43.43.

Heartflow Price Performance

Shares of HTFL stock opened at $48.10 on Friday. The stock has a market cap of $4.18 billion and a P/E ratio of -26.28. The company has a fifty day moving average price of $31.97 and a two-hundred day moving average price of $28.93. Heartflow, Inc. has a one year low of $20.13 and a one year high of $51.19.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business’s revenue was up 47.7% on a year-over-year basis. As a group, equities research analysts anticipate that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Heartflow Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.